SUS CLINICALS INC
Cincinnati, OH · Founded 2020 · CIK 0002007598 · Biotech · Private
Software platform for identifying and prioritizing promising cancer therapeutic candidates
susclinicals.com →- Grants
- $3.0M
- 3 awards
- Sector median: 1
- Raised
- $3.5M
- 1 Form D · Jan 2024
- 33 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓202320242025
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase II · Validation of the Genetically Malleable Oncopig Hepatocellular carcinoma (HCC) Model for Targeted Therapeutic Development | $964,276 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase II · Validation of the Genetically Malleable Oncopig Hepatocellular carcinoma (HCC) Model for Targeted Therapeutic Development | $964,276 | |
| Private capital raised | Form D · SEC | $3,504,636 | |
| Federal grant | Department of Health and Human Services · Phase II · Validation of the Genetically Malleable Oncopig Hepatocellular carcinoma (HCC) Model for Targeted Therapeutic Development | $1,035,724 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2320 | ARUKA BIO, INC. | — | $3.6M |
| 2321 | Genomics PLC | — | — |
| 2322 | Lennham Pharmaceuticals, Inc. | — | $3.5M |
| 2323 | SUS CLINICALS INC | — | $3.5M |
| 2324 | Myricx Bio | — | — |
| 2325 | Abiologics | — | — |
| 2326 | APT THERAPEUTICS, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Stephen BaggottDirector · Executive Officer
- Geoffrey MarshallDirector · Executive Officer
- Jeffrey WeedmanDirector · Executive Officer
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.